Analyst Activity – JPMorgan Chase & Co. Reiterates Neutral on GlaxoSmithKline (NYSE:GSK)

Analyst Ratings For GlaxoSmithKline (NYSE:GSK)

Story continues below

Today, JPMorgan Chase & Co. reiterated its Neutral rating on GlaxoSmithKline (NYSE:GSK).

Some recent analyst ratings include

  • 1/29/2018-JPMorgan Chase & Co. Reiterated Rating of Neutral.
  • 1/16/2018-Barclays Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
  • 11/6/2017-Investec was Downgraded by analysts at Investec from a “Buy ” rating to a ” Hold” rating.
  • 10/26/2017-Bank of America was Downgraded by analysts at Bank of America from a “Buy ” rating to a ” Neutral” rating.
  • 9/8/2017-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight ” rating to a ” Underweight” rating.

Dividend information for GlaxoSmithKline (NYSE:GSK)

GlaxoSmithKline (NYSE:GSK) pays an annual dividend of $2.04 with a yield of 5.29% and an average dividend growth of -8.90% based on a 3 Year Average..

Dividend History for GlaxoSmithKline (NYSE:GSK)

  • On 10/26/2017 GlaxoSmithKline announced a quarterly dividend of $0.50 5.51% with an ex dividend date of 11/9/2017 which will be payable on 1/11/2018.
  • On 7/26/2017 GlaxoSmithKline announced a Quarterly dividend of $0.49 4.88% with an ex dividend date of 8/9/2017 which will be payable on 10/12/2017.
  • On 4/26/2017 GlaxoSmithKline announced a quarterly dividend of $0.48 4.79% with an ex dividend date of 5/10/2017 which will be payable on 7/13/2017.
  • On 2/8/2017 GlaxoSmithKline announced a quarterly dividend of $0.57 5.76% with an ex dividend date of 2/22/2017 which will be payable on 4/13/2017.
  • On 10/26/2016 GlaxoSmithKline announced a dividend of $0.46 with an ex dividend date of 11/2/2016 which will be payable on 1/12/2017.
  • On 7/27/2016 GlaxoSmithKline announced a dividend of $0.49 with an ex dividend date of 8/10/2016 which will be payable on 10/13/2016.
  • On 4/28/2016 GlaxoSmithKline announced a dividend of $0.55 with an ex dividend date of 5/11/2016 which will be payable on 7/14/2016.

Recent Insider Trading Activity For GlaxoSmithKline (NYSE:GSK)
GlaxoSmithKline (NYSE:GSK) has insider ownership of 10.00% and institutional ownership of 9.70%.

  • On 11/6/2017 Plc Glaxosmithkline, Major Shareholder, bought 428,571 with an average share price of $14.00 per share and the total transaction amounting to $5,999,994.00.
  • On 10/24/2016 Plc Glaxosmithkline, Major Shareholder, bought 66,500 with an average share price of $14.00 per share and the total transaction amounting to $931,000.00.

Recent Trading Activity for GlaxoSmithKline (NYSE:GSK)
Shares of GlaxoSmithKline closed the previous trading session at 27.84 down -0.18 0.64% with 682797 shares trading hands.

An ad to help with our costs